“HPV vaccination and allocative efficiency: regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions” (2012) Farmeconomia. Health economics and therapeutic pathways, 13(2S), pp. 3–15. doi:10.7175/fe.v13i2S.449.